nobiletin has been researched along with Cancer of the Thyroid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dang, WJ; Du, QJ; Guo, JJ; Li, Q; Wang, H; Yan, Q; Zhou, RH | 1 |
| Cavaco, BM; Leite, V; Pinto, AT; Pojo, M; Serra, AT; Sousa, DP | 1 |
2 other study(ies) available for nobiletin and Cancer of the Thyroid
| Article | Year |
|---|---|
An investigation into the mechanism of nobiletin's inhibition of papillary thyroid cancer using network pharmacology analysis and experimental pharmacology.
Topics: Databases, Genetic; ErbB Receptors; Flavones; Humans; Iodine Radioisotopes; Molecular Docking Simulation; Network Pharmacology; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2023 |
Nobiletin Alone or in Combination with Cisplatin Decreases the Viability of Anaplastic Thyroid Cancer Cell Lines.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Cell Survival; Cisplatin; Dietary Supplements; Drug Therapy, Combination; Flavones; Humans; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tumor Cells, Cultured | 2020 |